The Board of Directors is made up of 10 to 13 members including a patient advocate, with each of six Founding Partners nominating one board member. In principle, Board members serve for a term of four years. The Board of Directors elects the Chair, the Secretary and the Treasurer among its members. The Board of Directors is then free to appoint up to 5 additional board members that fill skill areas not represented by the board members appointed by the Founding Partners or the patient advocate. The Chairs of the DNDi Scientific Advisory Committee and the GARDP Scientific Advisory Committee as well as the DNDi Executive Director are permanent invitees. Our regional entities are governed by regional Boards of Directors.

 

 

Picture of Marie-Paule KienyMarie-Paule Kieny, Chair; Institut national de la santé et de la recherche médicale (INSERM), France Suerie MoonSuerie Moon, Secretary; Harvard University, United States
Marcel TannerMarcel Tanner, Treasurer; University of Basel and Federal Institute of Technology Alwyn MwingaAlwyn Mwinga, Patient representative; Zambart, Zambia
Dr. Noor Hisham Abdullah Noor Hisham Abdullah, Ministry of Health, Malaysia Jorge BermudezJorge Bermudez, Fundação Oswaldo Cruz, Brazil
Stewart Cole, Institut Pasteur, FranceStewart Cole Joanne LiuJoanne Liu, Médecins Sans Frontières (MSF)
Bernards_Ogutu_1Bernhards Ogutu, Kenya Medical Research Institute (KEMRI), Kenya Bennett ShapiroBennett Shapiro, PureTech Ventures, formerly with Merck & Co., USA

 

John ReederJohn Reeder, WHO – TDR
Permanent Observer of Board